Showing results (71-80 of 181) with videos related to
Sort By:
Pageof 19
Infectious Disorders Drug Targets|March 21, 2026
In Vitro, In Silico, and Scanning Electron Microscopy Study of Anti-leishmanial Efficacy of New Synthetic 3-Imidazolyl Flavan Fxime on Leishmania tropicaAzar Shokri, Mahdi Fakhar, Saeed Hoseini Teshnizi, et al.Journal of Fluorescence|December 2, 2023
Synthesis, Sensing Performance and DFT Studies of a Novel Coumarin-based Schiff Base As a Turn-on Fluorescence Probe for Zinc Ion DetectionSeyedeh Mahdieh Hashemi, Seyed Ershad Moradi, Roudabeh Mohsseni Ahangar, et al.European Journal of Medicinal Chemistry|May 13, 2019
Novel 99mTc-2-arylimidazo[2,1-b]benzothiazole derivatives as SPECT imaging agents for amyloid-β plaquesSajjad Molavipordanjani, Saeed Emami, Alireza Mardanshahi, et al.Archiv Der Pharmazie|February 19, 2015
Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitorsSakineh Dadashpour, Tuba Tuylu Kucukkilinc, Oya Unsal Tan, et al.European Journal of Medicinal Chemistry|May 20, 2008
Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluationFatemeh Poorrajab, Sussan Kabudanian Ardestani, Saeed Emami, et al.Archiv Der Pharmazie|October 28, 2024
Multi-functional tyrosinase inhibitors derived from kojic acid and hydroquinone-like diphenols for treatment of hyperpigmentation: Synthesis and in vitro biological evaluationMorteza Ashooriha, Mehdi Khoshneviszadeh, Maryam Kabiri, et al.Molecular Diversity|June 9, 2018
New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agentsHojat-Allah Arab, Mohammad Ali Faramarzi, Nasrin Samadi, et al.Journal of Biochemical and Molecular Toxicology|February 27, 2023
Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agentsHamideh Ahadi, Mohammad Shokrzadeh, Zahra Hosseini-Khah, et al.Bioorganic & Medicinal Chemistry|March 7, 2008
Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazinesMina Behrouzi-Fardmoghadam, Fatemeh Poorrajab, Sussan Kaboudanian Ardestani, et al.European Journal of Medicinal Chemistry|January 29, 2023
Design, synthesis and biological activity of hybrid antifungals derived from fluconazole and mebendazoleElham Ghobadi, Seyedeh Mahdieh Hashemi, Hamed Fakhim, et al.Pageof 19